Recent Updates
Recently added Catalysts
TVTX Positive Sentiment

Travere Therapeutics to Participate at Upcoming Investor Conferences

Tuesday, November 3, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Travere Therapeutics announced its participation in several upcoming investor conferences. Management will present at the Guggenheim Global Healthcare Conference on November 10, 2026, and at the Stifel 2026 Healthcare Conference on November 11, 2026. Additional presentations are scheduled for the UBS Global Biopharma Conference and the Jefferies London Healthcare Conference.

Market Sentiment Analysis

POSITIVE FACTORS

  • Company management will present at multiple conferences.
  • Engagement with investors shows confidence in business.
  • Participation in notable healthcare conferences.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+24%
120-day peak, hindsight
Typical move
10.2%
average across 11 past catalysts
Lead asset
L-Citrulline
Phase 3 · Sickle Cell Disease

Full Press Release Details

SAN DIEGO--(BUSINESS WIRE)---- $TVTX--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company management will participate in the following upcoming investor conferences:Guggenheim Global Healthcare ConferencePresenting on Tuesday, November 10, 2026, at 8:00 a.m. ETStifel 2026 Healthcare ConferencePresenting on Wednesday, November 11, 2026, at 3:20 p.m. ETUBS Global Biopharma ConferencePresenting on Monday, November 16, 2026, at 11:20 a.m. GMTJefferies London Healthcare ConferencePresenting

Frequently Asked Questions

When will Travere present at the Guggenheim Conference?

Travere will present on November 10, 2026, at 8:00 a.m. ET.

What other conferences will Travere attend?

They will also present at the Stifel and UBS Global Biopharma Conferences.

What is the significance of these conferences?

These conferences provide a platform for investor engagement and company updates.

Where is the Jefferies London Healthcare Conference held?

The Jefferies Conference is scheduled for November 16, 2026.

ShareAdd on Google
Tags: TVTX Travere Therapeutics investor conferences healthcare conference biopharma conference
Last updated: Nov 3, 2026

Biotech snapshot

Cash runway
$472M liquidity · $0M/mo burn
Low dilution risk
Lead asset
L-CitrullinePhase 3
Sickle Cell Disease →

Catalyst track record

+24%
best trade around TVTX's most recent catalyst

Peak hindsight return over a 120-day window, across 11 tracked FDA/PDUFA catalysts for TVTX.

See every catalyst's timing & PoA →